Evidence map›Paper›PMID 22285752›Full record

ArticleMolecular cell2012

The WTX tumor suppressor enhances p53 acetylation by CBP/p300.

Woo Jae Kim, Miguel N Rivera, Erik J Coffman, Daniel A Haber

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The role of acetylation and deacetylation in cancer metabolism.Clinical and translational medicine · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Treatment of Brain Edema by Wogonoside Is Associated with Inhibition of Neuronal Apoptosis and SIRT1 Activation in Rats.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Woo Jae KimMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Miguel N Rivera
Erik J Coffman
Daniel A Haber
Harvard University · USHoward Hughes Medical Institute · US

Funding

Treating the P13-Kinase/AKTP50CA101942 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Wanling Xie · 2003 to 2026
$53.4M
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGYT32CA009216 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Michael Langenau · 1985 to 2026
$10.6M
Functional Properties of the Wilms' Tumor Gene WT1R37CA058596 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A. · 2003 to 2011
$3.9M
Howard Hughes Medical InstituteNCI NIH HHS 5R37CA058596NCI NIH HHS P50 CA101942NCI NIH HHS P50CA101942NCI NIH HHS R37 CA058596NCI NIH HHS T32 CA009216NCI NIH HHS T32CA009216
6 · The paper itself

Abstract

WTX encodes a tumor suppressor, frequently inactivated in Wilms tumor, with both plasma membrane and nuclear localization. WTX has been implicated in β-catenin turnover, but its effect on nuclear proteins is unknown. We report an interaction between WTX and p53, derived from the unexpected observation of WTX, p53, and E1B 55K colocalization within the characteristic cytoplasmic body of adenovirus-transformed kidney cells. In other cells without adenovirus expression, the C-terminal domain of WTX binds to the DNA-binding domain of p53, enhances its binding to CBP, and increases CBP/p300-mediated acetylation of p53 at Lys 373/382. WTX knockdown accelerates CBP/p300 protein turnover and attenuates this modification of p53. In p53-reconstitution experiments, cell-cycle arrest, apoptosis, and p53 target-gene expression are suppressed by depletion of WTX. Together, these results suggest that WTX modulates p53 function, in part through regulation of its activator CBP/p300.

Indexed as

AcetylationAdaptor Proteins, Signal TransducingHEK293 CellsHumansp300-CBP Transcription FactorsProtein StabilityTumor Suppressor Protein p53Tumor Suppressor ProteinsAdaptor Proteins, Signal TransducingAMER1 protein, humanp300-CBP Transcription FactorsTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID22285752
PMCPMC3310179
OpenAlexW2019418354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.